489 related articles for article (PubMed ID: 27498142)
1. Oral pirfenidone protects against fibrosis by inhibiting fibroblast proliferation and TGF-β signaling in a murine colitis model.
Li G; Ren J; Hu Q; Deng Y; Chen G; Guo K; Li R; Li Y; Wu L; Wang G; Gu G; Li J
Biochem Pharmacol; 2016 Oct; 117():57-67. PubMed ID: 27498142
[TBL] [Abstract][Full Text] [Related]
2. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
3. Suppression of TGF-β pathway by pirfenidone decreases extracellular matrix deposition in ocular fibroblasts in vitro.
Stahnke T; Kowtharapu BS; Stachs O; Schmitz KP; Wurm J; Wree A; Guthoff RF; Hovakimyan M
PLoS One; 2017; 12(2):e0172592. PubMed ID: 28231275
[TBL] [Abstract][Full Text] [Related]
4. Pirfenidone prevents radiation-induced intestinal fibrosis in rats by inhibiting fibroblast proliferation and differentiation and suppressing the TGF-β1/Smad/CTGF signaling pathway.
Sun YW; Zhang YY; Ke XJ; Wu XJ; Chen ZF; Chi P
Eur J Pharmacol; 2018 Mar; 822():199-206. PubMed ID: 29374548
[TBL] [Abstract][Full Text] [Related]
5. 3-(2-Oxo-2-phenylethylidene)-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-one (compound 1), a novel potent Nrf2/ARE inducer, protects against DSS-induced colitis via inhibiting NLRP3 inflammasome.
Wang Y; Wang H; Qian C; Tang J; Zhou W; Liu X; You Q; Hu R
Biochem Pharmacol; 2016 Feb; 101():71-86. PubMed ID: 26588861
[TBL] [Abstract][Full Text] [Related]
6. Intestinal anti-inflammatory activity of apigenin K in two rat colitis models induced by trinitrobenzenesulfonic acid and dextran sulphate sodium.
Mascaraque C; González R; Suárez MD; Zarzuelo A; Sánchez de Medina F; Martínez-Augustin O
Br J Nutr; 2015 Feb; 113(4):618-26. PubMed ID: 25654996
[TBL] [Abstract][Full Text] [Related]
7. Effect of pirfenidone on proliferation, TGF-β-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts.
Conte E; Gili E; Fagone E; Fruciano M; Iemmolo M; Vancheri C
Eur J Pharm Sci; 2014 Jul; 58():13-9. PubMed ID: 24613900
[TBL] [Abstract][Full Text] [Related]
8. Pregnane X receptor agonists enhance intestinal epithelial wound healing and repair of the intestinal barrier following the induction of experimental colitis.
Terc J; Hansen A; Alston L; Hirota SA
Eur J Pharm Sci; 2014 May; 55():12-9. PubMed ID: 24486481
[TBL] [Abstract][Full Text] [Related]
9. Effects of alanyl-glutamine dipeptide on the expression of colon-inflammatory mediators during the recovery phase of colitis induced by dextran sulfate sodium.
Hou YC; Chu CC; Ko TL; Yeh CL; Yeh SL
Eur J Nutr; 2013 Apr; 52(3):1089-98. PubMed ID: 22847641
[TBL] [Abstract][Full Text] [Related]
10. Decreased Fibrogenesis After Treatment with Pirfenidone in a Newly Developed Mouse Model of Intestinal Fibrosis.
Meier R; Lutz C; Cosín-Roger J; Fagagnini S; Bollmann G; Hünerwadel A; Mamie C; Lang S; Tchouboukov A; Weber FE; Weber A; Rogler G; Hausmann M
Inflamm Bowel Dis; 2016 Mar; 22(3):569-82. PubMed ID: 26848518
[TBL] [Abstract][Full Text] [Related]
11. Oridonin derivative ameliorates experimental colitis by inhibiting activated T-cells and translocation of nuclear factor-kappa B.
Liu QQ; Wang HL; Chen K; Wang SB; Xu Y; Ye Q; Sun YW
J Dig Dis; 2016 Feb; 17(2):104-12. PubMed ID: 26718746
[TBL] [Abstract][Full Text] [Related]
12. An HDAC6 Inhibitor Confers Protection and Selectively Inhibits B-Cell Infiltration in DSS-Induced Colitis in Mice.
Do A; Reid RC; Lohman RJ; Sweet MJ; Fairlie DP; Iyer A
J Pharmacol Exp Ther; 2017 Jan; 360(1):140-151. PubMed ID: 27827303
[TBL] [Abstract][Full Text] [Related]
13. Wu-Mei-Wan ameliorates chronic colitis-associated intestinal fibrosis through inhibiting fibroblast activation.
Wu F; Shao Q; Hu M; Zhao Y; Dong R; Fang K; Xu L; Zou X; Lu F; Li J; Chen G
J Ethnopharmacol; 2020 Apr; 252():112580. PubMed ID: 31972322
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Targeting of Nrf2 Signaling by Maggot Extracts Ameliorates Inflammation-Associated Intestinal Fibrosis in Chronic DSS-Induced Colitis.
Wang R; Wang D; Wang H; Wang T; Weng Y; Zhang Y; Luo Y; Lu Y; Wang Y
Front Immunol; 2021; 12():670159. PubMed ID: 34456904
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment with alanyl-glutamine suppresses T-helper-cell-associated cytokine expression and reduces inflammatory responses in mice with acute DSS-induced colitis.
Chu CC; Hou YC; Pai MH; Chao CJ; Yeh SL
J Nutr Biochem; 2012 Sep; 23(9):1092-9. PubMed ID: 22137260
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine regulates intestinal epithelial apoptosis via TGF-beta-related signaling.
Satoh Y; Ishiguro Y; Sakuraba H; Kawaguchi S; Hiraga H; Fukuda S; Nakane A
Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G514-9. PubMed ID: 19608730
[TBL] [Abstract][Full Text] [Related]
17. Effect of Pirfenidone on Vascular Proliferation, Inflammation and Fibrosis in an Abdominal Adhesion Rat Model.
Hasdemir PS; Ozkut M; Guvenal T; Uner MA; Calik E; Koltan SO; Koyuncu FM; Ozbilgin K
J Invest Surg; 2017 Feb; 30(1):26-32. PubMed ID: 27715339
[TBL] [Abstract][Full Text] [Related]
18. Lactobacillus acidophilus Improves Intestinal Inflammation in an Acute Colitis Mouse Model by Regulation of Th17 and Treg Cell Balance and Fibrosis Development.
Park JS; Choi JW; Jhun J; Kwon JY; Lee BI; Yang CW; Park SH; Cho ML
J Med Food; 2018 Mar; 21(3):215-224. PubMed ID: 29336663
[TBL] [Abstract][Full Text] [Related]
19. Berberine inhibits colitis-associated tumorigenesis via suppressing inflammatory responses and the consequent EGFR signaling-involved tumor cell growth.
Li D; Zhang Y; Liu K; Zhao Y; Xu B; Xu L; Tan L; Tian Y; Li C; Zhang W; Cao H; Zhan YY; Hu T
Lab Invest; 2017 Nov; 97(11):1343-1353. PubMed ID: 28759012
[TBL] [Abstract][Full Text] [Related]
20. Transanal delivery of angiotensin converting enzyme inhibitor prevents colonic fibrosis in a mouse colitis model: development of a unique mode of treatment.
Koga H; Yang H; Adler J; Zimmermann EM; Teitelbaum DH
Surgery; 2008 Aug; 144(2):259-68. PubMed ID: 18656634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
